Aerobics for Eyes, LLC

Advancing Cognitive Health Through Early Detection and Neurocognitive Training

Aerobics for Eyes, LLC has developed:

  • a rapid web-based cognitive screening procedure designed for scalable early detection
  • a patented 3D cognitive training platform supported by clinical research
Research Cited ByMayo ClinicU.S. Dept. of TransportationAir Force ReserveUniversity of MarylandNHTSA

— The Problem

A Critical Gap in Cognitive Health Infrastructure

Cognitive decline is one of the most significant — and underserved — health challenges facing the global population.

Widespread Population Impact

Cognitive decline, dementia, and visual-cognitive impairment affect millions of older adults — as well as pilots, drivers, athletes, and individuals with reading deficiencies.

Inadequate Detection Tools

Existing diagnostic procedures are expensive, time-consuming, inaccessible, or administered too late for meaningful clinical intervention.

No Scalable Solution

The market lacks a validated, science-backed platform combining accessible early detection with measurable cognitive improvement at scale.

— The Platform

An Integrated Cognitive Health Platform

Aerobics for Eyes is developing two complementary products built on decades of applied research and legacy intellectual property.

2025

VMdetect™

Rapid Web-Based Cognitive Screening

  • 5-minute, IRB-exempt screening procedure
  • Measures vision processing speed as a cognitive biomarker
  • Operable on any internet-connected device
  • Immediate results — no lab or clinic required
  • Applicable for monitoring dementia, stroke, autism, and brain trauma
2027

VMaerobics™

Cognitive Training & Performance Program

  • 10-minute 3D web-based training program
  • Improves vision processing speed, memory, and decision-making
  • Built on the patented original AfE methodology (U.S. Patent, 1991)
  • Validated against findings of the landmark ACTIVE Study
  • Designed for scalable SaaS delivery

— Scientific Foundation

Decades of Evidence. Independent Validation.

The platform rests on legacy intellectual property, internally conducted clinical studies, and findings consistent with landmark large-scale cognitive research.

87%

of participants improved Vision Processing Speed in the ACTIVE Study (JAMA, 2002)

2,832

volunteers aged 65–94 in the landmark ACTIVE randomized controlled trial

7–14 yrs

of expected cognitive decline equivalent reversed by training interventions

ACTIVE Study: Ball, K. et al. "Effects of Cognitive Training Interventions With Older Adults: A Randomized Controlled Trial." JAMA, Vol. 288, No. 18, November 13, 2002.

View Full Scientific Overview

— Investor Relations

Speak With Our Team

We welcome inquiries from investors, advisors, and clinical collaborators.

Contact — Speak With Our Team

We welcome inquiries from investors, clinical advisors, research partners, and collaborators in cognitive health and neurotechnology.

Investor Inquiries

We are currently advancing development of VMdetect and VMaerobics. If you are interested in the opportunity, please reach out directly or complete the form.

Clinical & Research Collaboration

We welcome dialogue with healthcare institutions, research organizations, and clinical practitioners interested in cognitive screening and training.

General Contact

Aerobics for Eyes, LLC · [email protected]

Aerobics for Eyes

© 2026 Aerobics for Eyes, LLC. All rights reserved.
VMdetect™ and VMaerobics™ are trademarks of Aerobics for Eyes, LLC.

Advisory Team

  • David BentonIT Advisor, Wells Fargo
  • Dr. William McDonaldMedical Advisor, Cornell Medical School
  • Samuel RichessonHR Advisor, Deputy Fire Chief Worcester MA
  • Spencer SullivanConsumer Product Strategy, PepsiCo Retired
  • Jaeson LeeInternational Markets Advisor
  • Christopher Edwards Esq.Legal Counsel, Reiter Kinkle & Rosenblatt LLP

[email protected] · A product of Aerobics for Eyes, LLC · Website by Carefree Creative